CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)	Common Stock [Member]	Common Stock Be Issued [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2020	$ 70	$ 336,000	$ 42,773,378		$ (45,893,368)	$ (2,783,920)
Beginning balance, shares at Dec. 31, 2020	695,576
Stock issued for conversion of non-redeemable convertible notes	$ 357		11,150,067			11,150,424
Stock issued for conversion of non-redeemable convertible notes, shares	3,552,025
Stock issued for conversion of convertible notes	$ 15		446,435			446,450
Stock issued for conversion of convertible notes, shares	146,868
Stock issued for the conversion of Series C Stock	$ 23		508,905			508,928
Stock issued for the conversion of Series C Stock, shares	225,000
Stock issued for consulting	$ 4		290,996			291,000
Stock issued for consulting, shares	40,500
Stock issued for officer and director compensation	$ 1		110,849			110,850
Stock issued for officer and director compensation, shares	42,000
Net loss					(12,929,226)	(12,929,226)
Ending balance, value at Sep. 30, 2021	$ 470	336,000	55,280,630		(58,822,594)	(3,205,494)
Ending balance, shares at Sep. 30, 2021	4,701,969
Beginning balance, value at Dec. 31, 2020	$ 70	336,000	42,773,378		(45,893,368)	(2,783,920)
Beginning balance, shares at Dec. 31, 2020	695,576
Ending balance, value at Dec. 31, 2021	$ 600	336,000	58,151,817	4,870	(62,229,405)	(3,736,118)
Ending balance, shares at Dec. 31, 2021	6,000,000
Beginning balance, value at Jun. 30, 2021	$ 190	336,000	46,902,968		(50,771,897)	(3,532,739)
Beginning balance, shares at Jun. 30, 2021	1,903,793
Stock issued for conversion of non-redeemable convertible notes	$ 246		7,565,944			7,566,190
Stock issued for conversion of non-redeemable convertible notes, shares	2,459,980
Stock issued for conversion of convertible notes	$ 8		228,316			228,324
Stock issued for conversion of convertible notes, shares	83,196
Stock issued for the conversion of Series C Stock	$ 23		508,905			508,928
Stock issued for the conversion of Series C Stock, shares	225,000
Stock issued for officer and director compensation	$ 3		74,497			74,500
Stock issued for officer and director compensation, shares	30,000
Net loss					(8,050,697)	(8,050,697)
Ending balance, value at Sep. 30, 2021	$ 470	336,000	55,280,630		(58,822,594)	(3,205,494)
Ending balance, shares at Sep. 30, 2021	4,701,969
Beginning balance, value at Dec. 31, 2021	$ 600	336,000	58,151,817	4,870	(62,229,405)	(3,736,118)
Beginning balance, shares at Dec. 31, 2021	6,000,000
Rounding on reverse split	$ 1					1
Rounding on reverse split, shares	5,558
Stock issued for conversion of non-redeemable convertible notes	$ 2,241		3,707,649			3,709,890
Stock issued for conversion of non-redeemable convertible notes, shares	22,410,000
Stock issued for officer and director compensation	$ 9,000		13,491,000			13,500,000
Stock issued for officer and director compensation, shares	90,000,000
Stock issued for the conversion of Series B Stock	$ 1,000		98,802			99,802
Stock issued for the conversion of Series B Stock, shares	10,000,000
Stock issued for the conversion of Series D Stock	$ 400		39,521			39,921
Stock issued for the conversion of Series D Stock, shares	4,000,000
Deemed dividend - Series A Stock modification			(1,396,721)			(1,396,721)
Deemed contribution - Series B Stock modification			1,354,515			1,354,515
Deemed contribution - Series C Stock modification			834,001			834,001
Deemed contribution - Series D Stock modification			749,085			749,085
Cancellation of Series A Stock			1,746,538			1,746,538
Cancellation of common stock
Cancellation of common stock, shares	(12,934)
Foreign exchange loss				37,928		37,928
Net loss					(18,760,538)	(18,760,538)
Ending balance, value at Sep. 30, 2022	$ 13,242	336,000	78,776,207	42,798	(80,989,943)	(1,821,696)
Ending balance, shares at Sep. 30, 2022	132,402,624
Beginning balance, value at Jun. 30, 2022	$ 12,342	336,000	76,235,088	6,571	(79,930,563)	(3,340,562)
Beginning balance, shares at Jun. 30, 2022	123,415,558
Stock issued for conversion of non-redeemable convertible notes	$ 300		735,300			735,600
Stock issued for conversion of non-redeemable convertible notes, shares	3,000,000
Stock issued for the conversion of Series B Stock	$ 600		59,281			59,881
Stock issued for the conversion of Series B Stock, shares	6,000,000
Cancellation of Series A Stock			1,746,538			1,746,538
Cancellation of common stock
Cancellation of common stock, shares	(12,934)
Foreign exchange loss				36,227		36,227
Net loss					(1,059,380)	(1,059,380)
Ending balance, value at Sep. 30, 2022	$ 13,242	$ 336,000	$ 78,776,207	$ 42,798	$ (80,989,943)	$ (1,821,696)
Ending balance, shares at Sep. 30, 2022	132,402,624